title: Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis.
abstract: BACKGROUND
  Obliterative bronchiolitis (OB), chronic allograft rejection of the lung, is a major cause of morbidity and mortality after lung transplantation. Previous studies using the heterotopic mouse trachea model of chronic airway rejection have shown a T cell infiltrate composed of CD4+ and CD8+ T cells. The goal of these experiments was to characterize the pattern of T lymphocyte cytokines during chronic airway rejection using the heterotopic mouse trachea model.
  
  
  METHODS
  Isografts (BALB/c into BALB/c) and allografts (BALB/c into C57BL/6) were implanted into cyclosporin-treated animals and harvested 2, 4, 6, and 10 weeks posttransplant. Cytokine mRNA expression in these grafts was determined using reverse transcription polymerase chain reactions. Expression of Th1 cytokines, interleukin- (IL) 2 and gamma-interferon, and Th2 cytokines, IL-4, and IL-10 were analyzed, as well as the cytotoxic lymphocyte product granzyme B and expressed relative to beta-actin gene expression.
  
  
  RESULTS
  In allografts, expression of IL-2 (P=0.002), gamma-interferon (P=2x10(-6)), granzyme B (P=0.003), IL-4 (P=0.06), and IL-10 (P=8x10(-6)) were 2- to 10-fold higher compared to isografts throughout the time-course of graft injury. Th1 and cytotoxic lymphocyte gene expression were increased to a greater extent than Th2 cytokines in allografts compared with isografts, and both Th1 and Th2 cytokine gene expression persisted at 6-10 weeks.
  
  
  CONCLUSIONS
  These data suggest that Th1, Th2, and cytotoxic lymphocyte subtypes all contribute to the development of obliterative bronchiolitis in the heterotopic mouse trachea model. Efforts to reduce the development of obliterative bronchiolitis may require the antagonism of multiple T cell pathways.
authors.affiliation: Department of Pulmonary/Critical Care Medicine and Cystic Fibrosis Research and Treatment Center, The University of North Carolina at Chapel Hill, 27599, USA.
authors.forename: I P
authors.initials: IP
authors.lastname: Neuringer
authors.forename: S P
authors.initials: SP
authors.lastname: Walsh
authors.forename: R B
authors.initials: RB
authors.lastname: Mannon
authors.forename: S
authors.initials: S
authors.lastname: Gabriel
authors.forename: R M
authors.initials: RM
authors.lastname: Aris
mesh_terms: D000818:Animals; D001989:Bronchiolitis Obliterans / Q000276:immunology*; D016207:Cytokines / Q000276:immunology*; D016040:Lung Transplantation / Q000009:adverse effects*; D051379:Mice; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014181:Transplantation Immunology; D014185:Transplantation, Isogeneic
chemical_list: D016207:Cytokines